Cargando…

Ganglion Cell Loss in the Course of Central Serous Chorioretinopathy

INTRODUCTION: Central serous chorioretinopathy (CSCR) as a clinical entity is potentially damaging and may significantly affect retinal morphology and function, especially in the chronic form. Our study aimed to determine the amount of deficit of best corrected visual acuity (BCVA) and individual re...

Descripción completa

Detalles Bibliográficos
Autores principales: Gawęcki, Maciej, Grzybowski, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834473/
https://www.ncbi.nlm.nih.gov/pubmed/36510030
http://dx.doi.org/10.1007/s40123-022-00625-5
_version_ 1784868467155927040
author Gawęcki, Maciej
Grzybowski, Andrzej
author_facet Gawęcki, Maciej
Grzybowski, Andrzej
author_sort Gawęcki, Maciej
collection PubMed
description INTRODUCTION: Central serous chorioretinopathy (CSCR) as a clinical entity is potentially damaging and may significantly affect retinal morphology and function, especially in the chronic form. Our study aimed to determine the amount of deficit of best corrected visual acuity (BCVA) and individual retinal layers, including ganglion cells, in different types of CSCR and with reference to its duration. METHODS: The retrospective analysis included 69 eyes of patients with resolved CSCR managed in Dobry Wzrok Ophthalmological Clinic between 1 January 2019 and 30 June 2022. The diagnosis of CSCR was based on the criteria outlined by the Central Serous Chorioretinopathy International Group. The analysis included data obtained from medical history, BCVA testing, and spectral domain optical coherence tomography (SD-OCT) measurements, with specific thickness values for individual retinal layers. The results were compared among affected eyes, unaffected fellow eyes, and healthy controls. RESULTS: BCVA values were significantly lower in acute (0.08 ± 0.12 logMAR) and chronic (0.26 ± 0.19 logMAR) cases versus controls (0.0 logMAR). The thickness of all retinal layers (central subfoveal thickness, CST; inner retina with ganglion cell complex, GC; outer retina, ORT; and photoreceptor outer segments, POS) and macular volume (MV) were significantly decreased in chronic eyes versus controls (p < 0.01). Acute eyes had significant thinning of the outer retina and POS only compared to control eyes (p < 0.01). The amount of deficit in CST, ORT, GC, and MV was strongly correlated with poorer BCVA (p < 0.001), and the deficit of CST, ORT, and GC was correlated with disease duration (p < 0.05). The subfoveal choroidal thickness was significantly greater in affected and fellow eyes versus controls (p < 0.001). CONCLUSION: Damage to the outer retina and photoreceptors occurs early in the course of CSCR, with a deficit in ganglion cells noted adjunctively in chronic forms of the disease. Further studies are required to precisely determine correlation between visual loss in CSCR and deficits in individual retinal layers.
format Online
Article
Text
id pubmed-9834473
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-98344732023-01-13 Ganglion Cell Loss in the Course of Central Serous Chorioretinopathy Gawęcki, Maciej Grzybowski, Andrzej Ophthalmol Ther Original Research INTRODUCTION: Central serous chorioretinopathy (CSCR) as a clinical entity is potentially damaging and may significantly affect retinal morphology and function, especially in the chronic form. Our study aimed to determine the amount of deficit of best corrected visual acuity (BCVA) and individual retinal layers, including ganglion cells, in different types of CSCR and with reference to its duration. METHODS: The retrospective analysis included 69 eyes of patients with resolved CSCR managed in Dobry Wzrok Ophthalmological Clinic between 1 January 2019 and 30 June 2022. The diagnosis of CSCR was based on the criteria outlined by the Central Serous Chorioretinopathy International Group. The analysis included data obtained from medical history, BCVA testing, and spectral domain optical coherence tomography (SD-OCT) measurements, with specific thickness values for individual retinal layers. The results were compared among affected eyes, unaffected fellow eyes, and healthy controls. RESULTS: BCVA values were significantly lower in acute (0.08 ± 0.12 logMAR) and chronic (0.26 ± 0.19 logMAR) cases versus controls (0.0 logMAR). The thickness of all retinal layers (central subfoveal thickness, CST; inner retina with ganglion cell complex, GC; outer retina, ORT; and photoreceptor outer segments, POS) and macular volume (MV) were significantly decreased in chronic eyes versus controls (p < 0.01). Acute eyes had significant thinning of the outer retina and POS only compared to control eyes (p < 0.01). The amount of deficit in CST, ORT, GC, and MV was strongly correlated with poorer BCVA (p < 0.001), and the deficit of CST, ORT, and GC was correlated with disease duration (p < 0.05). The subfoveal choroidal thickness was significantly greater in affected and fellow eyes versus controls (p < 0.001). CONCLUSION: Damage to the outer retina and photoreceptors occurs early in the course of CSCR, with a deficit in ganglion cells noted adjunctively in chronic forms of the disease. Further studies are required to precisely determine correlation between visual loss in CSCR and deficits in individual retinal layers. Springer Healthcare 2022-12-12 2023-02 /pmc/articles/PMC9834473/ /pubmed/36510030 http://dx.doi.org/10.1007/s40123-022-00625-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Research
Gawęcki, Maciej
Grzybowski, Andrzej
Ganglion Cell Loss in the Course of Central Serous Chorioretinopathy
title Ganglion Cell Loss in the Course of Central Serous Chorioretinopathy
title_full Ganglion Cell Loss in the Course of Central Serous Chorioretinopathy
title_fullStr Ganglion Cell Loss in the Course of Central Serous Chorioretinopathy
title_full_unstemmed Ganglion Cell Loss in the Course of Central Serous Chorioretinopathy
title_short Ganglion Cell Loss in the Course of Central Serous Chorioretinopathy
title_sort ganglion cell loss in the course of central serous chorioretinopathy
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834473/
https://www.ncbi.nlm.nih.gov/pubmed/36510030
http://dx.doi.org/10.1007/s40123-022-00625-5
work_keys_str_mv AT gaweckimaciej ganglioncelllossinthecourseofcentralserouschorioretinopathy
AT grzybowskiandrzej ganglioncelllossinthecourseofcentralserouschorioretinopathy